Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription Articles published in Lancet Retrieve available abstracts of 206 articles: HTML format

Single Articles

March 2026
1. JERNIGAN DB, Rivers CM
   Learning from swine influenza, Ebola virus disease, and Legionnaires' disease in 1976.
   Lancet. 2026 Mar 19:S0140-6736(26)00460-5. doi: 10.1016/S0140-6736(26)00460.
   PubMed    
   
   
   February 2026
2. NYBERG ST, Frank P, Ahmadi-Abhari S, Pentti J, et al
   Adult obesity and risk of severe infections: a multicohort study with global burden estimates.
   Lancet. 2026 Feb 9:S0140-6736(25)02474-2. doi: 10.1016/S0140-6736(25)02474.
   PubMed     Abstract available
   
   
   January 2026
3. WHITAKER M, Elliott J, Gerard-Ursin I, Cooke GS, et al
   Profiling vaccine attitudes and subsequent uptake in 1.1 million people in England: a nationwide cohort study.
   Lancet. 2026 Jan 12:S0140-6736(25)01912-9. doi: 10.1016/S0140-6736(25)01912.
   PubMed     Abstract available
   
   
   October 2025
4. JOHANSEN ND, Modin D, Pardo-Seco J, Rodriguez-Tenreiro-Sanchez C, et al
   Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis.
   Lancet. 2025 Oct 17:S0140-6736(25)01742-8. doi: 10.1016/S0140-6736(25)01742.
   PubMed     Abstract available
   
   
   
5. 
   Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
   Lancet. 2025 Oct 12:S0140-6736(25)01330-3. doi: 10.1016/S0140-6736(25)01330.
   PubMed     Abstract available
   
   
   
6. 
   Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Stud
   Lancet. 2025 Oct 12:S0140-6736(25)01637-X. doi: 10.1016/S0140-6736(25)01637.
   PubMed     Abstract available
   
   
   
7. REHM J, Assanangkornchai S, Hendershot CS, Franklin A, et al
   Alcohol use disorders.
   Lancet. 2025 Oct 9:S0140-6736(25)01496-5. doi: 10.1016/S0140-6736(25)01496.
   PubMed     Abstract available
   
   
   August 2025
8. ANDERSON CS, Hua C, Wang Z, Wang C, et al
   Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China.
   Lancet. 2025 Aug 28:S0140-6736(25)01485-0. doi: 10.1016/S0140-6736(25)01485.
   PubMed     Abstract available
   
   
   
9. BHATT AS, Vardeny O
   Influenza vaccination in heart failure: a shot worth taking?
   Lancet. 2025 Aug 28:S0140-6736(25)01679-4. doi: 10.1016/S0140-6736(25)01679.
   PubMed    
   
   
   July 2025
10. NEPOGODIEV D, Picciochi M, Ademuyiwa A, Adisa A, et al
    Surgical health policy 2025-35: strengthening essential services for tomorrow's needs.
    Lancet. 2025 Jul 14:S0140-6736(25)00985-7. doi: 10.1016/S0140-6736(25)00985.
    PubMed     Abstract available
    
    
    June 2025
11. 
    Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed     Abstract available
    
    
    March 2025
12. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed     Abstract available
    
    
    
13. THE LANCET
    H5N1 avian influenza: technical solutions, political challenges.
    Lancet. 2025;405:671.
    PubMed    
    
    
    January 2025
14. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed     Abstract available
    
    
    December 2024
15. DZAU VJ, Laitner MH, Shambaugh EL
    Strategic imperatives for health in the USA: a roadmap for the incoming presidential administration.
    Lancet. 2024;404:2371-2379.
    PubMed     Abstract available
    
    
    
16. 
    The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available
    
    
    October 2024
17. PAYNE AB, Watts JA, Mitchell PK, Dascomb K, et al
    Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
    Lancet. 2024;404:1547-1559.
    PubMed     Abstract available
    
    
    
18. BRANDA F, Oh J, Acharya KP, Yon DK, et al
    Human vaccination for highly pathogenic avian influenza.
    Lancet. 2024;404:1518-1519.
    PubMed    
    
    
    September 2024
19. ROMANELLO M, Costello A
    The Lancet Countdown on health and climate change: competing interests and optimism bias - Authors' reply.
    Lancet. 2024;404:1197-1198.
    PubMed    
    
    
    
20. BRINK N, Chersich MF
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196.
    PubMed    
    
    
    
21. BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196-1197.
    PubMed    
    
    
    
22. ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al
    The Lancet Countdown on health and climate change: representation matters - Authors' reply.
    Lancet. 2024;404:1195-1196.
    PubMed    
    
    
    
23. STREET R, Wright CY
    The Lancet Countdown on health and climate change: representation matters.
    Lancet. 2024;404:1194.
    PubMed    
    
    
    
24. HORTON R
    Offline: Xenotransplantation-a new era beckons.
    Lancet. 2024;404:1181.
    PubMed    
    
    
    
25. ELNAKIB S, Aly S, Asi YM, Shawar YR, et al
    The humanitarian system: politics can not be avoided.
    Lancet. 2024;404:1105-1106.
    PubMed    
    
    
    
26. ST LOUIS P, Makali SL, Paul E
    Health-care workers in fragile and conflict-ridden contexts.
    Lancet. 2024;404:1105.
    PubMed    
    
    
    
27. RAUSEI S, Bertolini AG
    Cuban doctors cannot be the definitive solution for Italy.
    Lancet. 2024;404:1103.
    PubMed    
    
    
    
28. YANG X, Zhang Z, Zhang Z
    Building safe health-care environments in China: urgent challenges.
    Lancet. 2024;404:1101-1102.
    PubMed    
    
    
    
29. HWANG TJ, Trinh QD, Sokolov E
    Safe and equitable use of clinical decision support systems.
    Lancet. 2024;404:1100-1101.
    PubMed    
    
    
    
30. HORTON R
    Offline: From Wanless to Darzi-don't miss this opportunity (again).
    Lancet. 2024;404:1088.
    PubMed    
    
    
    
31. MAZUR NI, Caballero MT, Nunes MC
    Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies.
    Lancet. 2024;404:1143-1156.
    PubMed     Abstract available
    
    
    
32. NACHEGA JB, Muyembe-Tamfum JJ, Ntoumi F, Mbala-Kingebeni P, et al
    A call for global solidarity and rapid action to control mpox.
    Lancet. 2024;404:1099-1100.
    PubMed    
    
    
    
33. IMANI-MUSIMWA P, Ververs M
    Mpox and breastmilk: for once, can we act in time?
    Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
    PubMed    
    
    
    
34. PECENKA C, Sparrow E, Feikin DR, Srikantiah P, et al
    Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
    Lancet. 2024 Sep 6:S0140-6736(24)01699-4. doi: 10.1016/S0140-6736(24)01699.
    PubMed     Abstract available
    
    
    August 2024
35. MACNAUGHTON J, Zeiler K
    Reimagining illness through post-COVID-19 condition: the need for radically interdisciplinary health research.
    Lancet. 2024;404:840-841.
    PubMed    
    
    
    
36. ZAROCOSTAS J
    Many challenges for WHO-AFRO regional director candidates.
    Lancet. 2024;404:736-737.
    PubMed    
    
    
    
37. ZHAO Y, Gao Y, Guyatt G, Uyeki TM, et al
    Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.
    Lancet. 2024;404:764-772.
    PubMed     Abstract available
    
    
    
38. GAO Y, Guyatt G, Uyeki TM, Liu M, et al
    Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.
    Lancet. 2024;404:753-763.
    PubMed     Abstract available
    
    
    
39. HUI DSC
    Antiviral treatment and prophylaxis for influenza.
    Lancet. 2024;404:726-727.
    PubMed    
    
    
    
40. BRANDA F, Ceccarelli G, Ciccozzi M, Scarpa F, et al
    Strengthening community resilience: lessons from COVID-19 for mpox prevention.
    Lancet. 2024 Aug 22:S0140-6736(24)01752-5. doi: 10.1016/S0140-6736(24)01752.
    PubMed    
    
    
    
41. SAMARASEKERA U
    Understanding pandemic risks: the WHO Pandemic Hub.
    Lancet. 2024;404:420-421.
    PubMed    
    
    
    
42. SHAH SA, Robertson C, Sheikh A
    Waiting list models must account for departures before treatment - Authors' reply.
    Lancet. 2024;404:432-433.
    PubMed    
    
    
    
43. WOOD RM
    Waiting list models must account for departures before treatment.
    Lancet. 2024;404:431-432.
    PubMed    
    
    
    
44. O'NEILL D
    Continuing challenges to health equity in Ireland.
    Lancet. 2024;404:431.
    PubMed    
    
    
    
45. BANATVALA JE, Muir P, Irving W, Meader E, et al
    The role of the clinical virologist in pandemic responses.
    Lancet. 2024;404:430.
    PubMed    
    
    
    
46. GARAY J, Kateeb E, Zeballos D, Souza LE, et al
    Inequity in sustainable health today.
    Lancet. 2024;404:429-430.
    PubMed    
    
    
    
47. GREEN A
    Evelyn Fox Keller.
    Lancet. 2024;404:426.
    PubMed    
    
    
    July 2024
48. GREENHALGH T, Sivan M, Perlowski A, Nikolich JZ, et al
    Long COVID: a clinical update.
    Lancet. 2024 Jul 31:S0140-6736(24)01136-X. doi: 10.1016/S0140-6736(24)01136.
    PubMed     Abstract available
    
    
    June 2024
49. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    PubMed    
    
    
    
50. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    PubMed    
    
    
    
51. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    PubMed    
    
    
    
52. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    PubMed    
    
    
    
53. SCHRECKER T
    Canada's reckoning?
    Lancet. 2024;403:2688.
    PubMed    
    
    
    
54. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    PubMed    
    
    
    
55. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed    
    
    
    
56. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed    
    
    
    
57. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed    
    
    
    
58. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed    
    
    
    
59. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed    
    
    
    
60. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed    
    
    
    
61. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed    
    
    
    
62. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    PubMed    
    
    
    
63. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed    
    
    
    
64. THE LANCET
    H5N1: international failures and uncomfortable truths.
    Lancet. 2024;403:2455.
    PubMed    
    
    
    
65. MOHAPATRA PR
    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed    
    
    
    
66. ANIRVAN P
    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed    
    
    
    
67. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed    
    
    
    
68. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed    
    
    
    
69. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed    
    
    
    
70. HORTON R
    Offline: UK election-two issues you won't hear about.
    Lancet. 2024;403:2362.
    PubMed    
    
    
    May 2024
71. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed    
    
    
    
72. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed    
    
    
    
73. BROWN M, Gerrard J, McDougall C, MacPhail J, et al
    Purpura fulminans in young women with influenza and co-infections.
    Lancet. 2024;403:2290-2291.
    PubMed    
    
    
    
74. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed    
    
    
    
75. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed     Abstract available
    
    
    
76. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    PubMed    
    
    
    
77. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    PubMed    
    
    
    
78. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed    
    
    
    
79. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    PubMed    
    
    
    
80. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    PubMed    
    
    
    
81. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed    
    
    
    
82. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed    
    
    
    
83. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed    
    
    
    
84. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed    
    
    
    
85. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed    
    
    
    
86. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed    
    
    
    
87. KOJIMA N, Adlhoch C, Mitja O, Dat VQ, et al
    Building global preparedness for avian influenza.
    Lancet. 2024 May 9:S0140-6736(24)00934-6. doi: 10.1016/S0140-6736(24)00934.
    PubMed    
    
    
    
88. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    PubMed    
    
    
    
89. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed    
    
    
    April 2024
90. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    PubMed    
    
    
    
91. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    PubMed    
    
    
    
92. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    PubMed    
    
    
    
93. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available
    
    
    
94. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    PubMed    
    
    
    
95. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    PubMed    
    
    
    
96. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    PubMed    
    
    
    
97. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    PubMed    
    
    
    
98. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    PubMed    
    
    
    
99. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    PubMed    
    
    
    
100. HASHIM Z, Nath A, Tripathy NK
     High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
     Lancet. 2024;403:1337-1338.
     PubMed    
     
     
     
101. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
     Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
     Lancet. 2024;403:1336.
     PubMed    
     
     
     
102. GU X, Huang L, Zhang H, Cao B, et al
     Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
     Lancet. 2024;403:1336-1337.
     PubMed    
     
     
     
103. 
     Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
     Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
     PubMed     Abstract available
     
     
     March 2024
104. SZANYI J, Howe S, Blakely T
     The importance of reporting accurate estimates of long COVID prevalence.
     Lancet. 2024;403:1136-1137.
     PubMed    
     
     
     
105. WENHAM C, Stout L
     A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
     Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
     PubMed     Abstract available
     
     
     
106. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
     Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
     Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
     PubMed    
     
     
     
107. 
     Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
     Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
     PubMed     Abstract available
     
     
     
108. PARHIZ H, Atochina-Vasserman EN, Weissman D
     mRNA-based therapeutics: looking beyond COVID-19 vaccines.
     Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
     PubMed     Abstract available
     
     
     February 2024
109. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
     The INSPIRE study: RSV infection during infancy - Authors' reply.
     Lancet. 2024;403:729-730.
     PubMed    
     
     
     
110. HSU NC, Hsu CH
     The INSPIRE study: RSV infection during infancy.
     Lancet. 2024;403:729.
     PubMed    
     
     
     
111. TAO L, Liu J
     The INSPIRE study: RSV infection during infancy.
     Lancet. 2024;403:728-729.
     PubMed    
     
     
     
112. DHAIRYAWAN R
     Candour, care, and COVID-19.
     Lancet. 2024;403:718.
     PubMed    
     
     
     
113. VORA NM, Hassan L, Plowright RK, Horton R, et al
     The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
     Lancet. 2024;403:597-599.
     PubMed    
     
     
     
114. WANG X, Li Y, Shi T, Bont LJ, et al
     Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
     Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
     PubMed     Abstract available
     
     
     
115. ADERINTO N, Olatunji G, Kokori E
     Health implications of GSK's departure from Nigeria.
     Lancet. 2024;403:526-527.
     PubMed    
     
     
     January 2024
116. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
     The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
     Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
     PubMed     Abstract available
     
     
     
117. WANG L, Wang Q, Gao GF
     Interpreting COVID-19 data from China: a call for caution - Authors' reply.
     Lancet. 2024;403:144-145.
     PubMed    
     
     
     
118. QU Z
     Interpreting COVID-19 data from China: a call for caution.
     Lancet. 2024;403:144.
     PubMed    
     
     
     
119. GULLIFORD MC, Steves CJ
     Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
     Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
     PubMed    
     
     
     
120. 
     Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
     Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
     PubMed     Abstract available
     
     
     
121. SHAH SA, Robertson C, Sheikh A
     Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
     Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
     PubMed    
     
     
     December 2023
122. CHARLIER P
     Death and end of life in France after COVID-19.
     Lancet. 2023;402:2290.
     PubMed    
     
     
     
123. HORTON R
     Offline: Boris Johnson and COVID-19-more light than heat.
     Lancet. 2023;402:2277.
     PubMed    
     
     
     November 2023
124. GRABAR-KITAROVIC K, Phumaphi J
     A crisis of trust in pandemic prevention, preparedness, and response.
     Lancet. 2023;402:1730-1732.
     PubMed    
     
     
     
125. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
     Impact of long COVID-19 on work: a co-produced survey.
     Lancet. 2023;402 Suppl 1:S98.
     PubMed     Abstract available
     
     
     
126. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
     The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
     Lancet. 2023;402 Suppl 1:S94.
     PubMed     Abstract available
     
     
     
127. 
     Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
     Lancet. 2023;402 Suppl 1:S74.
     PubMed     Abstract available
     
     
     
128. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
     Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
     Lancet. 2023;402 Suppl 1:S71.
     PubMed     Abstract available
     
     
     
129. MARTIN A, Jamieson S
     Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
     Lancet. 2023;402 Suppl 1:S68.
     PubMed     Abstract available
     
     
     
130. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
     Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
     Lancet. 2023;402 Suppl 1:S62.
     PubMed     Abstract available
     
     
     
131. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
     Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
     Lancet. 2023;402 Suppl 1:S61.
     PubMed     Abstract available
     
     
     
132. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
     Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
     Lancet. 2023;402 Suppl 1:S60.
     PubMed     Abstract available
     
     
     
133. HAZIR SG, Ryan C, Moore A, Lewis C, et al
     The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
     Lancet. 2023;402 Suppl 1:S47.
     PubMed     Abstract available
     
     
     
134. DU Z, Wang L, Bai Y, Pei Y, et al
     Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
     Lancet. 2023;402 Suppl 1:S39.
     PubMed     Abstract available
     
     
     
135. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
     Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
     Lancet. 2023;402 Suppl 1:S23.
     PubMed     Abstract available
     
     
     October 2023
136. WANG Q, Bowen A, Ho J, Zhang RM, et al
     SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
     Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
     PubMed    
     
     
     
137. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
     Scientific advisory councils in the COVID-19 response.
     Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
     PubMed    
     
     
     September 2023
138. MATUCHANSKY C
     Natural SARS-CoV-2 infection-induced immune protection against re-infection.
     Lancet. 2023;402:1131.
     PubMed    
     
     
     
139. FLACCO ME, Martellucci CA, Manzoli L
     Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
     Lancet. 2023;402:1129.
     PubMed    
     
     
     
140. YANG C, Lapp L, Tebbutt SJ
     Overcoming COVID-19 vaccine hesitancy hurdles.
     Lancet. 2023;402:1129-1130.
     PubMed    
     
     
     
141. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
     Striving to afford free health care in Greece during COVID-19.
     Lancet. 2023;402:1128-1129.
     PubMed    
     
     
     
142. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
     Long COVID in low-income and middle-income countries: the hidden public health crisis.
     Lancet. 2023;402:1115-1117.
     PubMed    
     
     
     
143. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
     COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
     Lancet. 2023;402:1132.
     PubMed    
     
     
     
144. QU Z
     Cautionary notes on the COVID-19 re-infection study.
     Lancet. 2023;402:1130-1131.
     PubMed    
     
     
     
145. ZHOU YB, Xu ZG
     COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
     Lancet. 2023;402:1131-1132.
     PubMed    
     
     
     
146. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
     Community COVID-19 response in WHO's European region.
     Lancet. 2023;402:1127.
     PubMed    
     
     
     
147. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
     Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
     Lancet. 2023;402:1041-1042.
     PubMed    
     
     
     
148. PARENTE RCM, Queiroga M
     Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
     Lancet. 2023;402:1040-1041.
     PubMed    
     
     
     
149. ZHANG H
     COVID-19 and Chinese nurses' mental health.
     Lancet. 2023;402:1039-1040.
     PubMed    
     
     
     August 2023
150. DAI L, Duan H, Liu X, Zhou H, et al
     Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
     Lancet. 2023;402:687-689.
     PubMed    
     
     
     
151. KUNG S, Hills T, Kearns N, Beasley R, et al
     New Zealand's COVID-19 elimination strategy and mortality patterns.
     Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
     PubMed    
     
     
     
152. IFTEKHAR N, Sivan M
     Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
     Lancet. 2023;402:e9.
     PubMed    
     
     
     
153. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
     Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
     Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
     PubMed     Abstract available
     
     
     July 2023
154. HSU NC, Hsu CH
     COVID-19 and commerce complicate minimum unit pricing effects on health.
     Lancet. 2023;402:368.
     PubMed    
     
     
     
155. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
     COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
     Lancet. 2023;402:368-369.
     PubMed    
     
     
     
156. O'BRIEN KL, Lemango E
     The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
     Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
     PubMed    
     
     
     June 2023
157. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
     Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
     Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
     PubMed    
     
     
     
158. 
     The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
     Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
     PubMed     Abstract available
     
     
     
159. PELOSI A
     Disrespectful language about patients with long COVID.
     Lancet. 2023;401:2108.
     PubMed    
     
     
     
160. PRIYA GIRI S, Dubey A
     Loneliness in the time of COVID-19: an alarming rise.
     Lancet. 2023;401:2107-2108.
     PubMed    
     
     
     
161. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
     Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
     Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
     PubMed    
     
     
     
162. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
     Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
     Lancet. 2023;401:2021-2023.
     PubMed    
     
     
     
163. HUANG C, Huang L, Wang Y, Li X, et al
     6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
     PubMed     Abstract available
     
     
     
164. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
     Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
     Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
     PubMed     Abstract available
     
     
     
165. LAL A, Schwalbe N
     Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery.
     Lancet. 2023;401:1847.
     PubMed    
     
     
     May 2023
166. JAFFE S
     US health experts divided on social media age restrictions.
     Lancet. 2023;401:1757.
     PubMed    
     
     
     
167. 
     Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
     Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
     PubMed    
     
     
     
168. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
     No time for complacency on COVID-19 in Europe.
     Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
     PubMed    
     
     
     
169. ZAROCOSTAS J
     With the COVID-19 PHEIC over, what next?
     Lancet. 2023;401:1642-1643.
     PubMed    
     
     
     
170. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
     Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
     Lancet. 2023;401:1649.
     PubMed    
     
     
     
171. JAFFE S
     US Surgeon General: loneliness is a public health crisis.
     Lancet. 2023;401:1560.
     PubMed    
     
     
     
172. EMANUEL EJ, Persad G
     The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
     Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
     PubMed     Abstract available
     
     
     April 2023
173. AGRAWAL U, Robertson C, Sheikh A
     Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
     Lancet. 2023;401:1424.
     PubMed    
     
     
     
174. BRANCH-ELLIMAN W, Monach PA
     Moving towards a precision approach for prevention of severe COVID-19.
     Lancet. 2023;401:1423-1424.
     PubMed    
     
     
     
175. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
     The importance of accountability in tackling future pandemics.
     Lancet. 2023;401:1423.
     PubMed    
     
     
     
176. GALVAO J
     COVID-19: forgetting a pandemic that is not over.
     Lancet. 2023;401:1422-1423.
     PubMed    
     
     
     
177. THE LANCET
     Moving past the COVID-19 emergency in the USA.
     Lancet. 2023;401:1399.
     PubMed    
     
     
     
178. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
     Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
     Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
     PubMed     Abstract available
     
     
     
179. CUENI T
     Lessons learned from COVID-19 to stop future pandemics.
     Lancet. 2023;401:1340.
     PubMed    
     
     
     
180. HORTON R
     Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
     Lancet. 2023;401:1324.
     PubMed    
     
     
     
181. LURIE N, Sharfstein JM
     State-to-state differences in US COVID-19 outcomes: searching for explanations.
     Lancet. 2023;401:1314-1315.
     PubMed    
     
     
     
182. BILLARD MN, Bont LJ
     The link between respiratory syncytial virus infection during infancy and asthma during childhood.
     Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
     PubMed    
     
     
     
183. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
     Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
     Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
     PubMed     Abstract available
     
     
     
184. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
     Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
     Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
     PubMed    
     
     
     
185. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
     Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
     Lancet. 2023;401:e20.
     PubMed    
     
     
     
186. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
     Characteristics of the omicron XBB subvariant wave in Singapore.
     Lancet. 2023;401:1261-1262.
     PubMed    
     
     
     
187. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
     Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
     Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
     PubMed     Abstract available
     
     
     
188. 
     Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
     Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
     PubMed     Abstract available
     
     
     
189. PERNER A, Venkatesh B
     Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
     Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
     PubMed    
     
     
     March 2023
190. SUN L, Jia H, Yang T
     Chinese medical personnel after the COVID-19 pandemic.
     Lancet. 2023;401:1000.
     PubMed    
     
     
     
191. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
     Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
     Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
     PubMed     Abstract available
     
     
     
192. QU Z
     International cooperation to end the COVID-19 pandemic.
     Lancet. 2023;401:820.
     PubMed    
     
     
     
193. THE LANCET
     Long COVID: 3 years in.
     Lancet. 2023;401:795.
     PubMed    
     
     
     
194. 
     Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
     Lancet. 2023;401:833-842.
     PubMed     Abstract available
     
     
     
195. COHEN C, Pulliam J
     COVID-19 infection, reinfection, and the transition to endemicity.
     Lancet. 2023;401:798-800.
     PubMed    
     
     
     
196. STOCKWELL M
     Effect of a nationwide intervention of electronic letters with behavioural nudges on influenza vaccination in older adults in Denmark.
     Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453.
     PubMed    
     
     
     
197. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
     Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
     Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349.
     PubMed     Abstract available
     
     
     
198. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
     Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
     Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
     PubMed    
     
     
     February 2023
199. HUANG S, Gao Z, Wang S
     China's COVID-19 reopening measures-warriors and weapons.
     Lancet. 2023;401:643-644.
     PubMed    
     
     
     
200. PAN Y, Wang L, Feng Z, Xu H, et al
     Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
     Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
     PubMed     Abstract available
     
     
     
201. PREISER W, Maponga T
     So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
     Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
     PubMed    
     
     
     January 2023
202. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
     Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
     Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
     PubMed     Abstract available
     
     
     
203. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
     Global and regional governance of One Health and implications for global health security.
     Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
     PubMed     Abstract available
     
     
     
204. TRAORE T, Shanks S, Haider N, Ahmed K, et al
     How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
     Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
     PubMed     Abstract available
     
     
     
205. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
     A global analysis of One Health Networks and the proliferation of One Health collaborations.
     Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
     PubMed     Abstract available
     
     
     October 2022
206. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
     After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
     Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum